Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.49 |
| ▸ | FDPS | P14324 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5136231 | 1.00 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| Formaldehyde SCHEMBL5704728 | 0.96 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL991834 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL6050718 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| Citronellic Acid SCHEMBL193354 | 0.85 | ALOX15 (0.55) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| Citronellic Acid SCHEMBL712982 | 0.85 | ALOX15 (0.55) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| Citronellic Acid SCHEMBL714852 | 0.85 | ALOX15 (0.55) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL5704674 | 0.83 | ALOX15 (0.46) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL1477739 | 0.83 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSTSHR | |
| SCHEMBL14418807 | 0.83 | ALOX15 (0.53) | ALOX15ALDH1A1GGPS1FDPSTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017205964-A1 | AMINOSTEROID DERIVATIVES AND PROCESS FOR PRODUCING SAME | UNIVERSITé LAVAL (CA) | 2017-12-07 | — | — | WO | disclosed |
| US-8653054-B2 | 2-(N-substituted piperazinyl) steroid derivatives | UNIVERSITE LAVAL (CA) | 2014-02-18 | — | — | US | disclosed |
| US-8653054-B2 | 2-(N-substituted piperazinyl) steroid derivatives | UNIVERSITE LAVAL (CA) | 2014-02-18 | — | — | US | disclosed |
| US-20110312926-A1 | 2-(N-Substituted Piperazinyl) Steroid Derivatives | UNIVERSITE LAVAL (CA) | 2011-12-22 | — | — | US | disclosed |
| US-20110312926-A1 | 2-(N-Substituted Piperazinyl) Steroid Derivatives | UNIVERSITE LAVAL (CA) | 2011-12-22 | — | — | US | disclosed |
| EP-1347035-B1 | Isomer composition containing optically active ethyl trans-2,2,6-trimethylcyclohexylcarboxylate and fragrance composition containing the isomer composition | TAKASAGO PERFUMERY CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| EP-1347036-B1 | Isomer composition excellent in chemical resistance containing optically active trans-1(2,2,6-trimethylcyclohexyl)-2-buten-1-one and fragrance composition containing the isomer composition | TAKASAGO PERFUMERY CO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-6930083-B2 | Isomer composition excellent in chemical resistance containing optically active trans-1-(2,2,6-trimethylcyclohexyl)-2-buten-1-one and fragrance compositions containing the isomer composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-08-16 | — | — | US | disclosed |
| EP-1162191-B1 | (1S,6R)- And/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone, process for producing the same, and perfume composition containing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2005-06-29 | — | — | EP | disclosed |
| EP-1468978-A1 | Process for producing (1S,6R)-2,2,6-trimethylcyclohexyl methyl ketone and/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone | Takasago International Corporation (JP) | 2004-10-20 | — | — | EP | disclosed |
| US-6770618-B2 | ORGANOLEPTIC; PLANT EXTRACTS; MIXTURES | TAKASAGO INTERNATIONAL CORP. (JP) | 2004-08-03 | — | — | US | disclosed |
| US-20030207790-A1 | Isomer composition excellent in chemical resistance containing optically active trans-1-(2,2,6-trimethylcyclohexyl)-2-buten-1-one and fragrance compositions containing the isomer composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-11-06 | — | — | US | disclosed |
| US-20030207789-A1 | Isomer composition containing optically active ethyl trans-2,2,6-trimethylcyclohexylcarboxylate and fragrance composition containing the isomer composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-11-06 | — | — | US | disclosed |
| EP-1347036-A2 | Isomer composition excellent in chemical resistance containing optically active trans-1(2,2,6-trimethylcyclohexyl)-2-buten-1-one and fragrance composition containing the isomer composition | Takasago International Corporation (JP) | 2003-09-24 | — | — | EP | disclosed |
| EP-1347035-A2 | Isomer composition containing optically active ethyl trans-2,2,6-trimethylcyclohexylcarboxylate and fragrance composition containing the isomer composition | Takasago International Corporation (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-20020042356-A1 | (1S,6R)-2,2,6-Trimethylcyclohexyl methyl ketone and/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone, process for producing the same, and perfume composition containing the same | TAKASAGO INTERNATIONAL CORP. (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-1162191-A2 | (1S,6R)- And/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone, process for producing the same, and perfume composition containing the same | Takasago International Corporation (JP) | 2001-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042356-A1 | (1S,6R)-2,2,6-Trimethylcyclohexyl methyl ketone and/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone, process for producing the same, and perfume composition containing the same | MINK1, TEKT1, TMT1A | ALOX15 1692/4885ALDH1A1 1508/4885GGPS1 246/4885 |
| US-20030207790-A1 | Isomer composition excellent in chemical resistance containing optically active trans-1-(2,2,6-trimethylcyclohexyl)-2-buten-1-one and fragrance compositions containing the isomer composition | TAS1R1, TAS1R2, TAS2R1 | ALOX15 689/4885ALDH1A1 128/4885GGPS1 890/4885 |
| US-20030207789-A1 | Isomer composition containing optically active ethyl trans-2,2,6-trimethylcyclohexylcarboxylate and fragrance composition containing the isomer composition | ETV1, ELP1, TAS1R2 | ALOX15 1129/4885ALDH1A1 599/4885GGPS1 1137/4885 |
| US-20110312926-A1 | 2-(N-Substituted Piperazinyl) Steroid Derivatives | NR5A1, HSD17B11, CYP17A1 | ALOX15 2932/4885ALDH1A1 556/4885GGPS1 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.